The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders

CompletedOBSERVATIONAL
Enrollment

139

Participants

Timeline

Start Date

July 5, 2016

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
SchizophreniaBipolar Disorder
Interventions
DIAGNOSTIC_TEST

Cognitive Function Assessments

The NIMH-Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) is a consensus battery that is considered state-of-the art in the evaluation of cognitive skills for schizophrenia research.(Burton et al., 2013, Harvey, 2014) The complete cognitive battery takes about one hour to administer, and is comprised of 10 subtests measuring seven essential domains of function, with very good reliability and validity.(Nuechterlein 2008, August et al., 2012) The MATRICS subtests have been incorporated into the cognitive battery described below, with supplementary subtests included where indicated within each domain.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03166098 - The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders | Biotech Hunter | Biotech Hunter